DHHS Adult ARV Guidelines
Interaction Color Code
Clinical Bottom Line
Do not coadminster: potentially increased levels of flibanserin
Drug 1
Drug 2
Mechanism
Inhibition of CYP3A4 by lenacapavir
Clinical Effects
Potential increased risk of GI adverse effects, insomnia, dry mouth, tachycardia
Management
Use alternative agents.
Info Source
